State Street Corporation 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 10:26 am Sale | 2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | STATE STREET CORP STT | 1,525,045 1.620% | -2,154,340 (-58.55%) | Filing |
| 2023-02-08 10:03 am Purchase | 2022-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | STATE STREET CORP STT | 3,679,385 6.040% | 3,679,385 (New Position) | Filing |